Benzinga's Top #PreMarket Losers

By: via Benzinga
Insmed (NASDAQ: INSM) shares declined 20.29% to $13.75 in pre-market trading after the company reported that it will file a Marketing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.